Yuanmai Cell Secures Tens of Millions in RMB Angel Funding to Advance CAR-Macrophage Immunotherapy
Dec 08, 2022 08:00
CST Updated
08:00
Macera Therapeutics
Macrophage Immunotherapy Drug Developer
CDH Investments.
Alternative Asset Management Investment Institutions
Yuanmai Cell
Angel RoundJiangsu Province2022-09
A platform company for the development of macrophage immunotherapy drugs
I Want to Contact